Rivero FTE, León AP, Pila PR, Rosales TP

Language: Spanish
References: 12
Page:
PDF size: 427.89 Kb.

ABSTRACT

The incidence of Idiopathic Inflammatory Myopathy is from 4 to 15 cases per million inhabitants and its prevalence of 60 per million inhabitants. Idiopathic dermatomyositis is more frequent in women; Although its association with pulmonary fibrosis is described, it is very infrequent, it is only reported in 2% of cases. To describe a diagnosed case of idiopathic dermatomyositis and pulmonary fibrosis. A 50-year-old patient presented weakness at the level of the shoulder girdle accompanied by fatigue. Physical examination: Skin: scratching lesions in different regions of the body due to pruritus, erythematous lesions at the level of the skin on both thighs. Osteomyoarticular system: generalized joint pains with functional impotence and progressive generalized myalgias and muscular hypotrophy of several muscle groups. The analytical study revealed elevated muscle enzymes. The skin and muscle biopsy showed elements suggestive of dermatomyositis. Chest X-ray: diffuse peribronchovascular infiltrate associated with fibrous path. Spirometry: restrictive ventilatory disorders of severe intensity. Computed tomography of the lung with alveolar consolidation and discrete pleural thickening. We report the case of a patient with idiopathic dermatomyositis and pulmonary fibrosis. This association is an uncommon finding in our environment and even more so when the patient is asymptomatic.

REFERENCES

1. Arnaud L, Amoura Z. Criterios de clasificación de las conectivopatías. EMC Tratado de Medicina. 2012;16(3):1-5.

2. Bohan A, Peter J. Polymyositis and Dermatomyositis. New Eng J Med. 1975;292:344-403.

3. Turrión Nieves AL, Martín Holguera R, Sánchez Atrio AL, Moruno Cruz H. Miopatías inflamatorias idiopáticas. Medicina. 2013;11(33):2040-7.

4. Miller F. Polimiositis y Dermatomiositis. En: Principios de Medicina Interna. Cecil-Goldman (eds.). 24 ed. Madrid: Ed. Elsevier; 2013. p. 1720-5.

5. Lazarou IN, Guerme FA. Classification, diagnosis and management of idiopathic inflammatory myopathies. J Rheumatol. 2013;40(5):550-64.

6. Svensson J, Arkema EV, Lundberg IE, Holmqvist M. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: A nationwide population-based study. Rheumatology (Oxford). 2017 May;56(1):802-10. DOI: http://dx.doi.org/10.1093/rheumatology/kew503

7. Russi J, Paz A, Valdes J, Rodríguez D, Valencia J, Mona G. Polimiositis y compromiso cardíaco. Acta Med Colom. 2014;39:293-97.

8. IE Lundberg, M de Visser, VP Werth. Classification of myositis. Nat Rev Rheumatol. 2018 May;14:269-27. DOI: http://dx.doi.org/10.1038/nrrheum.2018.41

9. Miller M, Vleugels R. Clinical manifestations of Dermatomyosytis and Polymyositis in adults. Up to date, 2013.

10. McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol. 2018 Apr;14(20):290-302. DOI: http://dx.doi.org/10.1038/nrrheum.2018.56

11. Bouza Jiménez Y, Núñez Paredes IM, Perez Rodríguez Y. Dermatomiositis. Presentación de un caso: Case presentation. Medisur. 2018;16(2):335-43.

12. Lundberg IE, Tjärnlund A, Bottai M. European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017 Dec;76:1955-64. DOI: http://dx.doi.org/10.1136/annrheumdis-2017-211468.